Equities
Consumer Staples Personal Care, Drug and Grocery Stores
  • Price (HKD)22.20
  • Today's Change0.55 / 2.54%
  • Shares traded3.64m
  • 1 Year change-17.47%
  • Beta0.6144
Data delayed at least 15 minutes, as of Sep 19 2024 09:08 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Hengan International Group Co Ltd is an investment holding company that is primarily engaged in the manufacture, distribution and sale of personal hygiene products. The Company operates in four segments: Sanitary Napkin Products segment, Disposable Diapers Products segment, Tissue Paper Products segment and Others segment. The Company's personal hygiene products include sanitary napkins, disposable baby diapers, handkerchiefs, tissues, kitchen paper towels and others. The Company is also engaged in the production and sale of household hygiene products such as skin care products, first aid products, paper cups, dishwashing liquids and others.

  • Revenue in HKD (TTM)25.71bn
  • Net income in HKD3.28bn
  • Incorporated--
  • Employees24.00k
  • Location
    Hengan International Group Company LtdHeng'an Industrial CityAnhai Town, Jinjiang CityQUANZHOU 362261ChinaCHN
  • Phone+86 59 585708888
  • Fax+86 5 957086666
  • Websitehttps://www.hengan.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Blue Moon Group Holdings Ltd8.23bn-170.97m13.25bn7.46k--1.42167.561.61-0.0317-0.03171.481.600.73058.139.031,034,556.00-1.527.71-1.759.5562.5561.25-2.0811.766.30--0.013156.21-7.841.59-46.79-10.10-5.28--
PALTAC Corp63.61bn1.16bn14.85bn2.24k12.760.96429.780.2334337.16337.1618,479.424,462.722.3819.925.25519,160,000.004.344.697.508.397.497.681.821.941.43--0.0023.994.332.567.200.8661-10.836.69
Pola Orbis Holdings Inc9.38bn534.64m18.17bn4.05k32.851.9218.551.9444.0744.07773.43755.160.84171.8810.5242,339,100.004.825.375.566.1881.8482.845.736.273.21--0.0003124.314.21-6.96-15.562.8712.16-8.25
Jyothy Labs Ltd2.62bn349.26m18.50bn2.94k52.91--46.607.0610.2210.2276.65--------9,553,653.00--11.16--14.5949.9643.6013.3310.14--505.02--51.5010.908.7454.1112.49-1.473.13
Fancl Corp6.01bn455.55m19.99bn1.28k40.874.2229.683.3368.5168.51904.24663.011.082.989.1186,027,430.008.207.9810.409.6366.9968.587.587.002.82--0.0052.357.03-1.9777.730.4219-7.932.53
Kobayashi Pharmaceutical Co Ltd9.47bn761.90m23.24bn3.53k29.531.9320.182.45184.09184.092,307.552,821.320.65422.674.7448,943,410.005.268.016.4110.1854.7256.458.0412.242.21--0.005433.194.330.70371.582.4529.678.88
Lion Corp22.38bn1.11bn24.34bn7.55k21.701.5110.251.0972.0272.021,451.451,032.180.85843.765.8154,107,680.004.795.637.048.9345.3047.605.596.451.20--0.096331.013.312.88-33.34-10.609.215.39
Hengan International Group Company Ltd25.71bn3.28bn24.66bn24.00k7.591.105.730.9592.852.8522.3619.710.49354.018.681,117,932.006.297.7013.6015.9134.8737.1412.7514.791.1012.230.495565.995.092.9945.46-5.9215.95-9.05
Kose Corp17.27bn798.38m26.32bn7.56k31.041.6218.331.52255.46255.465,524.984,892.200.84821.227.2441,709,980.004.24--5.41--69.99--5.00--2.78--0.0358--3.90---37.87------
Gillette India Limited2.45bn383.51m27.34bn571.0071.2830.2159.3711.15126.35126.35808.08298.071.412.738.86--21.9820.4737.9133.0358.1753.4915.6414.451.0463.130.0000573.856.307.1815.7510.24-2.2815.39
Emami Ltd3.41bn687.89m30.28bn3.29k44.02--35.248.8816.9216.9283.81--------11,123,460.00--20.43--27.9168.0865.5620.1718.75--52.01--53.895.065.8513.1319.00-21.8514.87
Giant Biogene Holding Co Ltd4.90bn1.94bn36.77bn1.16k18.205.6018.587.501.971.974.976.380.76492.9631.084,209,341.0030.24--36.89--82.74--39.53--3.62--0.0002--49.05--44.88------
Data as of Sep 19 2024. Currency figures normalised to Hengan International Group Company Ltd's reporting currency: Hong Kong Dollar HKD

Institutional shareholders

19.01%Per cent of shares held by top holders
HolderShares% Held
Lazard Asset Management LLCas of 31 May 202464.14m5.52%
Artisan Partners LPas of 20 Jan 202358.07m5.00%
The Vanguard Group, Inc.as of 04 Sep 202426.69m2.30%
Fidelity Management & Research Co. LLCas of 31 Jul 202413.40m1.15%
Dimensional Fund Advisors LPas of 05 Sep 202413.06m1.12%
Geode Capital Management LLCas of 12 Sep 202410.99m0.95%
BlackRock Fund Advisorsas of 05 Sep 202410.30m0.89%
Hang Seng Investment Management Ltd.as of 05 Sep 20248.75m0.75%
Wasatch Advisors LPas of 31 Mar 20248.52m0.73%
Norges Bank Investment Managementas of 31 Dec 20237.03m0.61%
More ▼
Data from 30 Jun 2024 - 30 Jun 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.